Clinical Trial Update: Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing veliparib plus FOLFIRI versus placebo plus FOLFIRI (with or without bevacizumab) in untreated metastatic colorectal cancer; trial comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)
• Veliparib (veliparib)

Snippet

Sponsor: AbbVie | Conditions: Untreated Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-11-20